Preparation and Application of Mucoadhesive Nanoparticles Containing Enoxaparin in a Wound Healing Animal Model

Author(s): Stephany Cares Huber, Priscyla Daniely Marcato, Nelson Duran, Andrea Monte Alto Costa, Joyce Maria Annichino-Bizzacchi

Journal Name: Current Nanoscience

Volume 10 , Issue 6 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The use of heparin or low molecular weight heparin (LMWH) is calling attention as an alternative for treating of skin ulcers. However, clinical topical application heparin has challenges such as stability, permeation and number of administrations. Thus, the encapsulation of heparin in nanoparticles may enable the clinical application of this molecule for the treatment of lesions. Therefore, the goal of this study was evaluated the use of free and encapsulated LMWH in mucoadhesive nanoparticles on acute skin lesions in an in vivo rat model. The polymeric nanoparticles was prepared using poly(ε-caprolactone) and chitosan in order to obtain a particle with mucoadhesive properties. Spherical nanoparticles with an average diameter of 511 nm and with positive superficial charge (+ 20 mV) were produced. In vivo experiments with free or encapsulated enoxaparin showed no beneficial effect upon the size of the skin lesions in comparison to controls. Furthermore, no renal, hepatic or hematological toxicity was detected in all groups analyzed. In conclusion, mucoadhesive particles with high encapsulation efficiency (98%) were produced, however with no favorable effect for the treatment of acute skin wounds.

Keywords: Biodegradable polymers, chitosan, low molecular weight heparin, polymeric nanoparticles, skin wounds, wound healing.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 12 October, 2014
Page: [779 - 785]
Pages: 7
DOI: 10.2174/1573413710666140812230749
Price: $65

Article Metrics

PDF: 15